Antiarrhythmic drugs for atrial fibrillation in the outpatient setting

被引:0
作者
Tseng, Andrew S. [1 ]
Desimone, Christopher V. [1 ]
Kowlgi, Gurukripa N. [1 ]
机构
[1] Mayo Clin, Dept Cardiovas Med, Rochester, MN USA
关键词
Atrial fibrillation; Cardiac arrhythmias; Outpatients; DIRECT ORAL ANTICOAGULANTS; HEART-FAILURE; DIGOXIN; DRONEDARONE; CAFFEINE; RISK; METAANALYSIS; ASSOCIATION; ARRHYTHMIAS; DOFETILIDE;
D O I
10.23736/S0026-4806.23.08524-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With burgeoning evidence for early rhythm control in patients with atrial fibrillation (AF), the management of AF in the outpatient setting has become more challenging. The primary care clinician often serves as the frontline in the pharmacologic management of AF. Because of drug interactions and the risk of proarrhythmia, many clinicians remain hesitant about the initiation and chronic management of antiarrhythmic drug prescriptions. However, with the likely increased use of antiarrhythmics for early rhythm control, understanding and familiarity with these medications have likewise become more important, especially since patients with AF probably have other non-cardiac medical conditions that can impact their antiarrhythmic therapy. In this comprehensive review, we provide informative, high-yield cases and edifying references that will help primary care providers become comfortable handling various clinical scenarios.
引用
收藏
页码:839 / 849
页数:11
相关论文
共 50 条
  • [31] Trials of New Antiarrhythmic Drugs for Maintenance of Sinus Rhythm in Patients with Atrial Fibrillation
    Steven Singh
    Journal of Interventional Cardiac Electrophysiology, 2004, 10 : 71 - 76
  • [32] Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants
    Wu, Victor Chien-Chia
    Wang, Chun-Li
    Huang, Yu-Chang
    Tu, Hui-Tzu
    Huang, Yu-Tung
    Huang, Chien-Hao
    Chen, Shao-Wei
    Kuo, Chang-Fu
    Hung, Kuo-Chun
    Chang, Shang-Hung
    EUROPACE, 2023, 25 (05):
  • [33] Trials of new antiarrhythmic drugs for maintenance of sinus rhythm in patients with atrial fibrillation
    Singh, S
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2004, 10 (01) : 71 - 76
  • [34] Prevention of attacks of atrial fibrillation by amiodarone in outpatient setting
    Bart, BY
    Smirnova, OL
    Larin, VG
    Morosovskaya, LA
    KARDIOLOGIYA, 1997, 37 (03) : 33 - 36
  • [35] Antiarrhythmic drugs management in patients with atrial fibrillation: the new guidelines
    Haitsma, D. B.
    De Groot, N. M. S.
    Jordaens, L.
    MINERVA CARDIOANGIOLOGICA, 2011, 59 (02): : 187 - 195
  • [36] Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation
    Duray, Gabor Z.
    Ehrlich, Joachim R.
    Hohnloser, Stefan H.
    CURRENT OPINION IN CARDIOLOGY, 2010, 25 (01) : 53 - 58
  • [37] Atrial fibrillation in the setting of cardiac amyloidosis - A review of the literature
    Bazoukis, George
    Saplaouras, Athanasios
    Efthymiou, Polyxeni
    Yiannikourides, Andronicos
    Liu, Tong
    Sfairopoulos, Dimitrios
    Korantzopoulos, Panagiotis
    Varrias, Dimitrios
    Letsas, Konstantinos P.
    Thomopoulos, Costas
    Tse, Gary
    Stavrakis, Stavros
    JOURNAL OF CARDIOLOGY, 2024, 84 (03) : 155 - 160
  • [38] Atrial fibrillation and the expanding role of catheter ablation: Do antiarrhythmic drugs have a future?
    Naccarelli, Gerald V.
    Gonzalez, Mario D.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2008, 52 (03) : 203 - 209
  • [40] Status of Antiarrhythmic Drug Development for Atrial Fibrillation New Drugs and New Molecular Mechanisms
    Hanley, Colleen M.
    Robinson, Victoria M.
    Kowey, Peter R.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2016, 9 (03)